These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21617009)

  • 1. Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis.
    Akpek G; Mikulski M; Kleinberg M; Badros A; Yanovich S; Rapoport AP
    Blood; 2011 May; 117(21):5772-4. PubMed ID: 21617009
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
    N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
    Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
    Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
    Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune reaction to human cytomegalovirus].
    Ito M
    Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients.
    Riddell SR; Reusser P; Greenberg PD
    Rev Infect Dis; 1991; 13 Suppl 11():S966-73. PubMed ID: 1664137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load.
    Reusser P; Cathomas G; Attenhofer R; Tamm M; Thiel G
    J Infect Dis; 1999 Aug; 180(2):247-53. PubMed ID: 10395836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.
    Riddell SR; Walter BA; Gilbert MJ; Greenberg PD
    Bone Marrow Transplant; 1994; 14 Suppl 4():S78-84. PubMed ID: 7728132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
    Micklethwaite K; Hansen A; Foster A; Snape E; Antonenas V; Sartor M; Shaw P; Bradstock K; Gottlieb D
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
    Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
    J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.
    Peggs KS; Verfuerth S; Pizzey A; Khan N; Guiver M; Moss PA; Mackinnon S
    Lancet; 2003 Oct; 362(9393):1375-7. PubMed ID: 14585640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
    Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
    J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation.
    Kato R; Tamaki H; Ikegame K; Yoshihara S; Kaida K; Taniguchi K; Inoue T; Ishii S; Nakata J; Fujioka T; Eguchi R; Soma T; Okada M; Ogawa H
    Ann Hematol; 2015 Oct; 94(10):1707-15. PubMed ID: 26193851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of cytomegalovirus specific cytotoxic T lymphocytes from a sero-negative donor can facilitate resolution of infection and immune reconstitution.
    Horn B; Bao L; Dunham K; Stamer M; Adler S; Cowan M; Lucas K
    Pediatr Infect Dis J; 2009 Jan; 28(1):65-7. PubMed ID: 19034064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation.
    Morita-Hoshi Y; Heike Y; Kawakami M; Sugita T; Miura O; Kim SW; Mori SI; Fukuda T; Tanosaki R; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2008 Mar; 41(6):515-21. PubMed ID: 18026143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
    Lindsley MD; Torpey DJ; Rinaldo CR
    J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.
    Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M
    Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.